Pharma Industry News Archive

Pharma Industry News: January 2009

January 2 2008 - The Year in Drugs
January 2 MedWatch - Innohep (tinzaparin sodium) Dear Healthcare Professional Letter Issued Re: Increased Risk of Death in Renal Impaired Elderly
January 2 Study is Among First to Link Short Term Drug Use for Osteoporosis to Bone Death
January 2 AMSA Applauds Pharma Ban; Continues to Call for Federal Regulation
January 5 Daiichi Sankyo Records Valuation Loss, Goodwill Write-down, on Investment in Ranbaxy Laboratories
January 5 PPD Enters Into Strategic Collaboration with Merck
January 5 Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals
January 5 Adventrx Announces Further Cost-Cutting Measures
January 6 Abbott Completes Acquisition of Ibis Biosciences, a Subsidiary of Isis
January 6 HealthCentral Amasses Top Three Online Health Audience; Study Reveals More Consumers Turned to Internet for Health Info Than Their Physician Last Year
January 6 CMS Reports Lowest Rate of Overall Growth in National Health Spending Since 1998
January 6 Advaxis' Phase II Clinical Trial “HOLD” Lifted
January 6 If You Take Erectile Dysfunction Medications, Read This List
January 7 Orion's Statutory Negotiations Completed. Personnel to be Reduced by About 205 in Finland
January 7 Daiichi Sankyo, Inc. Establishes Subsidiary in Puerto Rico
January 7 Sangart, Inc. Announces Key Executive Appointments and Company Restructuring
January 7 Bio-Imaging Technologies Sells CapMed Division to Metavante Technologies
January 7 Crucell and Wyeth in Discussion on a Combination of the Two Companies
January 8 Plexxikon and Roche Enter Second Partnership to Develop PLX5568 for Polycystic Kidney Disease
January 8 ICON plc Acquires Remaining 30% Stake in Beacon Bioscience Inc.
January 8 Hormone Therapy Associated With Reduced Colorectal Cancer Risk
January 9 Update of Safety Review Follow-up to the January 25, 2008 Early Communication about an Ongoing Data Review for Ezetimibe/Simvastatin (marketed as Vytorin), Ezetimibe (marketed as Zetia), and Simvastatin (marketed as Zocor)
January 9 UCB and Wilex to Enter Into Strategic Alliance to Develop UCB's Preclinical Oncology Portfolio
January 12 EpiCept Discontinues Drug Discovery Operations and Reduces Workforce
January 12 FDA Awaits Court's Entry of A Permanent Injunction Against Actavis Totowa, LLC
January 12 Abbott Announces Earnings Guidance for 2009
January 12 Pfizer Contributes Critical Data to URMC Drug Safety Initiative
January 13 FDA Announces Two Appointments
January 13 Elan to Review Strategic Business Alternatives
January 13 Bristol-Myers Squibb and ZymoGenetics Enter Global Collaboration on Novel Hepatitis C Compound
January 13 Merck KGaA and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis
January 13 Genzyme Reports Strong Fourth-Quarter and 2008 Revenue Growth  
January 13 Update of Safety Review Follow-up to the March 27, 2008, Communication about the Ongoing Safety Review of Montelukast (Singulair)
January 14 Merck Statement in Response to the FDA's Update Regarding a Safety Review of Singulair (montelukast)
January 14 Almost Three-Quarters (70%) of Online Canadians Have Visited a Healthcare Website in the Past Year
January 14 Use of Antidepressants Associated With Improvement in Symptoms of Fibromyalgia
January 14 Sen. Grassley Comments on FDA Tracking of Clinical Investigators’ Financial Ties
January 14 Nycomed Strengthens its Osteoporosis Portfolio
January 14 FDA Launches Pilot Program To Improve the Safety of Drugs and Active Drug Ingredients Produced Outside the United States
January 14 New Analysis Estimates Numbers of Older U.S. Adults Who May Benefit From Statin Therapy
January 15 Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices
January 15 Bionovo Announces Cost Control Measures Taken
January 15 Use of Atypical Antipsychotic Drugs Increases Risk of Sudden Cardiac Death in Adults
January 15 US Department of Health and Human Services Awards Novartis $486 Million Contract to Build Manufacturing Facility for Pandemic Flu Vaccine
January 15 Former Johnson & Johnson Executive Gives Big Voice to Small Companies
January 15 Johnson & Johnson Announces Satisfaction of Regulatory Clearances Condition for its Proposed Acquisition of Mentor Corporation
January 16 XOMA Announces Workforce Reduction
January 16 Genentech Announces Full Year and Fourth Quarter 2008 Results
January 20 Abbott Opens New Pharmaceutical Research Laboratory in Singapore
January 20 Physician Social Networkers are High Prescribers and More Likely to Engage with Pharma
January 20 Forest Laboratories, Inc. Reports Q3'09 Diluted Earnings Per Share of $0.62, Including $0.41 Per Share Charge for New Product Licensing Fees
January 20 Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results
January 20 Nile Therapeutics Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program
January 20 FDA Alerts Public about Danger of Skin Numbing Products
January 20 Teva and Lonza Announce Strategic Partnership to Become a Leading Global Provider of Biosimilars
January 20 Johnson & Johnson Completes Initial Tender Offer for Mentor Corporation with 92.9% of Shares Tendered
January 21 Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings
January 21 Medication May Provide Some Benefit for Older Adults With Anxiety Disorder
January 22 European Physician Tech Tools of the Trade - Wikipedia and Social Networking?
January 22 Biovitrum (SE) - Biovitrum aims to spin-out Cambridge Biotechnology
January 22 Akesis Pharmaceuticals Discontinues Sole Clinical Development Program and Announces Intent to File for Chapter 7 Bankruptcy
January 22 Novartis Launches Extavia, A New Therapeutic Option To Help Patients Combat Devastating Symptoms Of Multiple Sclerosis
January 22 Enlight Biosciences Expands to Direct up to $52 Million to Transformational Enabling Technologies
January 23 UCB to Divest Selected Smaller Markets to Further Focus on its Key Strategic Areas
January 23 Report: Pfizer May Buy Wyeth for $60 Billion
January 23 XTENT to Retain Investment Bank to Pursue Strategic Alternatives
January 23 GAO: High-Risk Series: An Update
January 23 Grassley Works to Disclose Financial Ties Between Drug Companies and Doctors
January 23 Penwest Sets Focused Priorities for 2009; Takes Actions to Further Reduce Costs
January 23 Lexicon Consolidates Operations to Focus Resources on Most Advanced Drug Discovery and Development Programs
January 23 Geron Receives FDA Clearance to Begin World's First Human Clinical Trial of Embryonic Stem Cell-Based Therapy
January 26 Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company
January 26 Pfizer Reports Fourth-Quarter and Full-Year 2008 Results and 2009 Financial Guidance
January 26 Crucell N.V. (NL) - Discussions on a Combination of Crucell and Wyeth Discontinued
January 26 Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company
January 26 MEDIA ADVISORY: Pfizer and Wyeth to Host Live Press Conference in New York
January 26 Administrative Law Judge Upholds HHS-OIG Exclusions Imposed Against Responsible Corporate Officers in OxyContin Case
January 26 Wyeth Reports Earnings Results for the 2008 Full Year and Fourth Quarter
January 26 Substantial Increase in Public Preference for Generic over Brand Name Drugs
January 26 Altus Pharmaceuticals Realigns Product Development Priorities and Focuses on Long-Acting Growth Hormone Candidate ALTU-238
January 26 KV Pharmaceutical Suspends Product Manufacturing, Shipping
January 27 Amgen's Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55
January 27 FDA Issues an Early Communication about an Ongoing Safety Review of clopidogrel bisulfate (marketed as Plavix)
January 27 Strong Fourth Quarter Supports Excellent 2008 for Bristol-Myers Squibb
January 27 Astellas Proposes to Acquire CV Therapeutics for $16 Per Share in Cash
January 27 Manhattan Research Survey Finds That Physicians Overwhelmingly Support Commercially-Funded Continuing Medical Education
January 27 Verified Physicians a Must for Ensuring Quality Data From Online Surveys, Finds Frost & Sullivan
January 28 CV Therapeutics Statement on Unsolicited Proposal From Astellas
January 28 Sequenom Terminates Exchange Offer to Acquire EXACT Sciences
January 28 Roche Delighted About Pool Extension
January 28 Strong Fourth Quarter Supports Excellent 2008 for Bristol-Myers Squibb
January 28 Gilead Sciences Announces Record Fourth Quarter and Full Year 2008 Financial Results
January 28 Pharmaceutical eNewsletters Launch “XTRA” Content
January 29 Lilly Reports Fourth-Quarter and Full-Year 2008 Results
January 29 AstraZeneca PLC - Fourth quarter and Full Year Results 2008
January 29 Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
January 29 Sepracor Announces Strategic Corporate Restructuring and Workforce Reduction Plan in Addition to 2009 Financial Guidance
January 29 Med Ad News’ 20th Annual Manny Awards Will Honor Healthcare Advertising Agencies
January 29 Actelion Pharmaceuticals Ltd (CH) - Zavesca (miglustat) receives EU approval for the treatment of progressive neurological manifestations in patients with Niemann-Pick type C disease
January 29 Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
January 29 Alexza Consolidates Operations to Focus Resources on AZ-004 (Staccato Loxapine) for Acute Agitation
January 30 Roche Intends to Commence Tender Offer to Acquire All Shares of Genentech for US$ 86.50 Per Share in Cash
January 30 FDA Sends Abbott Letter Regarding Depakote ER/Depakote Continuum Care Pharmacy Formulary Flashcard
January 30 Lilly Announces Senior Leadership Change
January 30 Kyowa Hakko Kirin Third Quarter Results; Revision of Full Year Forecasts; Planned Change of Fiscal Year End
January 30 Major Shareholders Criticize Enzon Pharmaceuticals Management Team in Open Letter
January 30 Special Committee of Genentech Board of Directors Responds to Roche's Announced Intention to Commence a Tender Offer

Pharma Industry News Archive

2009: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

MedNotes
Advertisement

(web4)